ABSTRACT
BACKGROUND
Haemolytic disease of the newborn secondary to Rhesus-D isoimmunisation contributes significantly to perinatal morbidity and mortality. Maternal Rh (D) alloimmunization occurs as a result of maternal immune system exposure in Rh negative women to Rh (D) positive red blood cells of the foetus as a result of transplacental foetomaternal haemorrhage during and pregnancy, injection with needles contaminated by Rh (D) positive blood or accidental transfusion of Rh (D) positive blood. Once, anti-D Ig antibodies are present in the pregnant women's circulation, they can cross the placenta and opsonise foetal RBC, which undergoes phagocytosis leading to haemolytic disease of the foetus, newborn ranging from hyperbilirubinaemia, severe anaemia to hydrops fetalis. Unlike the ABO blood group system, there is no preformed Rh antibody; only Rh-negative individuals are sensitised to produce the Rh antibody when they are transfused with Rh-positive blood.
India is a country with diversities based on race, religion and creed. Hence, diversity has been observed in the distribution of blood groups in the population. In India, the incidence of Rh-negative is 5-10%. 1 Rh incompatibility can pose a major problem in pregnancy when the mother is Rhnegative and foetus is Rh-positive.
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OBJECTIVE OF THE STUDY
The objective of this study was to estimate the prevalence of Rh-negative pregnancy in antenatal women and evaluate the maternal and foetal outcome in Rh-negative pregnancies.
MATERIALS AND METHODS
A retrospective observational study was conducted at Government Victoria Hospital, a tertiary care centre of Andhra Medical College, Visakhapatnam, Andhra Pradesh, for a period of one year, i.e. between October 2014 to September 2015 regarding prevalence of Rh-negative blood group in antenatal women with evaluation of maternal and perinatal outcome. Data was obtained from the inpatient register and OP register. ABO and RhD factor are part of the routine investigations during the antenatal booking of the women attending the antenatal clinics. Antibodies screening was routinely performed at booking and at 28 weeks of gestation on RhD negative women. Other information including age, address, previous obstetric history, transfusion history, social and family history, blood group systems of the husband or previous child of antenatal women, anti-D immunoglobulin prophylaxis administration and type of delivery, foetal outcome, baby blood group and jaundice was collected and analysed.
OBSERVATIONS AND RESULTS
The total number of Rh negative deliveries were 376 out of 8808 deliveries conducted in Government Victoria Hospital, Andhra Medical College, Visakhapatnam, during the 1 year period, i.e. between October 2014 to September 2015. Hence, the prevalence was 4.268%. Highest incidence was found in 21-25 years age group, i.e. 63.30% as many couples plan family during this age group (Table 1) . In our study, 42.02% were primigravida, which predominated over other parity ( Table 2 ). Many of the antenatal women had Ove blood group, i.e. about 52.66% (Table 3 ). Majority of subjects had normal deliveries, i.e. 60.37% and 31.92% delivered by caesarean section (Table 4 ). 99.47% had negative indirect Coombs test and only 0.53% had positive indirect Coombs test (Table 5 ). Out of 376 cases, 1.33% was fresh stillbirths and 1.33% macerated stillbirths (Table 6 ). 1.86% of neonates had Apgar of 0-4, whereas 1.32% of neonates had an Apgar score of 5-8 ( Table 7) . Majority of the babies were weighing between 2.5 to 3 kg, only one baby was weighing more than 4 kg ( Table 8) . Most of the babies had Rh-positive blood group, i.e. about 75.53% and 24.47% of babies had Rh-negative blood group ( Table 9) . Out of 41 babies, 33 babies had early onset of jaundice as they were Rh-positive babies needing SNCU admission (Table 10 ). 80.49% were admitted for neonatal jaundice suggesting mild Rh isoimmunisation (Table 11) . Majority of newborn babies, i.e. about 77.44% had bilirubin levels between 10-15 mg/dL (Table 12) .
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DISCUSSION
In our study, the prevalence of Rh-negative pregnancy was 4.268%. Our finding was consistent with previous reports obtained in Guinea, i.e., about 4.1% Rh negative pregnancies and 95.94% RhD positive cases 3 and Enugu, South East Nigeria, i.e. about 4.5% Rh-negative pregnancies. 4 Other documented RhD positive rates include 96.6% by Pramanik and Pramanik. 5 In Nepal, 93% by Bashwari et al 6 in the Eastern region of Saudi Arabia, 97.7% in West Bengal, India. 7 The prevalence of Rh-negative cases in Rajavithi Hospital was 0.31%. 8 In our study, highest prevalence was found in 21-25 years age group, i.e. 63.30% as many couples plan family during this age. In our study, the most common blood group with Rh-negative phenotype was O (52.66%), followed by B (23.14%), A (18.08%), AB (6.12%). The study from Enugu, South East Nigeria, showed that the most common blood group with Rh-negative phenotype was O (64.5%), followed by A (20%), blood group B 12.1% and AB 3.2%, respectively. 4 In the study by Agarwal S et al, the most common blood group with Rh negative phenotype was O (39%), A (17%), B (16%), AB (17%). 1 In the present study, 42.02% were primi gravida, which predominated over other parity. Primipara constituted 48.5% of the study population in a study by Adeyemi AS et al. 9 Since primipara constituted the greatest proportion of the RhD-negative obstetric population, there is need for defined protocol, which will make for proper and adequate management of this population so as not to compromise the reproductive career of these women. Nearly, 60.37% of women had normal deliveries and 31.92% delivered by caesarean section. Out of 376 antenatal Rh-negative cases, 8 cases developed preeclampsia, 5 cases developed foetal growth restriction with severe oligoamnios, 2 cases associated with GDM and 1 women had antepartum eclampsia.
Many developed nations have national antenatal screening program such as the Dutch screening programme in Netherlands and in Sweden. However, in developing countries, anti-D continues to be a common alloantibody found in pregnant women. In our study, 99.47% had negative indirect Coombs test and 0.53% had positive indirect Coombs test.
Regarding neonatal outcome, 366 were liveborn babies out of 376 and 5 were early neonatal deaths in our study. 97.34% were liveborn babies, 1.33% were fresh stillborn and 1.33% were macerated stillbirth. One patient had positive indirect Coombs test leading to stillbirth and another patient with positive ICT reported with IUD. One baby had dolichocephaly with undescended testes and features of IUGR. Baby expired 2 days after delivery.
Manifestation of the affected baby depends on the severity of isoimmunisation, i.e. hydrops fetalis, icterus gravis neonatorum or congenital anaemia of the newborn.
In our study, 1.86% had Apgar score of 0-4, 1.32% had 6-8 Apgar score and 6.94% had 8-10 Apgar score. Majority of newborn babies had Apgar score of (10), i.e. about 89.88%.
In our study, out of 366 liveborn babies, 41 babies were admitted in SNCU. Out of 41 babies, 33 babies had early onset of jaundice as they were Rh-positive babies needing SNCU admission. 5 babies had bilirubin levels more than 21 mg/dL and died within 7 days of birth. In a study by a higher proportion of neonates with Rh incompatibility, had hyperbilirubinaemia within 72 hours of life. Thus, neonates with Rh isoimmunisation had significantly higher incidence of jaundice within 72 hours of life.
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CONCLUSION
Despite the fact that the prevalence of Rh-ve pregnancy is lower <5% (in south India), Rh isoimmunisation remains a determining factor responsible for perinatal morbidity in most developing countries. Hence, the primary aim in caring for the RhD negative women is the prevention of alloimmunization. Every women should have her ABO blood group, Rh-type and antibody screen if Rh negative, checked at the first antenatal visit.
